Jovan Antovic

MD, Professor
Coagulation, Clinical Chemistry, Department Molecular Medicine & Surgery, Karolinska Institute & Clinical Chemistry & 24/7, Medical Diagnostics Karolinska, Karolinska University Hospital Stockholm Sweden
Stockholm, Stockholms Lan, Sweden

Presentation(s):

• PB0850 - Tocilizumab Reduces Hypercoagulation in COVID-19 - Perspectives from The Coagulation and Immunomodulation Covid Assessment Clinical Trial.

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB1013 - Hyperbilirubinemia is a limitation to the overall hemostatic potential assay

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT